Vardenafil Hydrochloride Tablet
Product Images NDC 42291-826

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Vardenafil Hydrochloride (NDC 42291-826). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (826 30)

FDA Label Image

Chemical Structure (Vardenafil Figure 1)

FDA Label Image

Figure 1 (Vardenafil Figure 2)

FDA Label Image

Figure 2 (Vardenafil Figure 3)

FDA Label Image

Figure 3 (Vardenafil Figure 4)

FDA Label Image

Figure 4 (Vardenafil Figure 5)

FDA Label Image

Figure 5 (Vardenafil Figure 6)

Figure 5 (Vardenafil Figure 6)
This text provides information on the mean change in blood pressure (measured in mmHg) at different time points for different dosages of Vardenafil (a medication) compared to a placebo. The data includes the effects of Vardenafil 5 mg, Vardenafil 10 mg, and placebo at different stages of the study (stage 1 and stage 2) over a certain period of time in hours.*
FDA Label Image

Figure 6 (Vardenafil Figure 7)

FDA Label Image

Figure 7 (Vardenafil Figure 8)

FDA Label Image

Figure 8 (Vardenafil Figure 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.